Jaswinder Singh, MD is a hematologist-oncologist who is also holds board-certification in internal medicine. Dr. Singh has dedicated his career to the improvement of the lives with those diagnosed with cancer. He has a specific interest in complex GI (gastrointestinal) cancers. He has been a key leader for the Liver and Pancreas tumor board which oversees the treatment planning for hundreds of patients annually. In the years he has been at a physician at Research Medical Center, he has previously served as a Medical Director for the Clinical Trials Program. Dr. Singh remains an advocate for clinical trials for the benefit of the patient and the elevation of therapies in the future. He also continues to support research through multiple publications of his own research along with sponsored protocols. His work in the areas of solid tumor diagnostics has also led to the increased utilization of molecular profiling across multiple patient populations, thereby identifying future and potential therapeutic avenues for patient care. Prior to joining Sarah Cannon at HCA Midwest Health, Dr. Singh completed his hematology-oncology fellowship at the University of Kansas Medical Center. Dr. Singh received his medical degree from Medical College, Chandigarh in India and served an internal medicine residency at Mount Sinai VA Medical Center in New York.